Alvotech (NASDAQ:ALVOW – Get Free Report) was the target of a significant increase in short interest in October. As of October 15th, there was short interest totaling 1,309 shares, an increase of 60.6% from the September 30th total of 815 shares. Based on an average trading volume of 1,621 shares, the days-to-cover ratio is presently 0.8 days.
Alvotech Stock Up 21.1%
Shares of ALVOW opened at $0.30 on Tuesday. Alvotech has a 52-week low of $0.12 and a 52-week high of $1.50. The firm’s fifty day moving average is $0.36 and its two-hundred day moving average is $0.30.
Alvotech Company Profile
Alvotech is a biotechnology company focused on developing and manufacturing biosimilar medicines. Biosimilars are biologic products designed to be highly similar to approved reference medicines and may provide additional treatment options in areas with significant healthcare costs. The company’s portfolio targets therapeutic categories including immunology, ophthalmology, oncology and other chronic conditions.
Alvotech operates an integrated business model that covers biosimilar research, cell-line development, process development, clinical testing and commercial-scale manufacturing.
See Also
- Five stocks we like better than Alvotech
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
